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Motor Cortex Layer V Pyramidal Neurons Exhibit Dendritic
Regression, Spine Loss, and Increased Synaptic Excitation in
the Presymptomatic hSOD1G93A Mouse Model of
Amyotrophic Lateral Sclerosis
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Motor cortex layerVpyramidalneurons (LVPNs) regulate voluntary control ofmotoroutput andselectivelydegenerate (alongwith lower
motor neurons) in amyotrophic lateral sclerosis. Using dye-filling and whole-cell patch clamping in brain slices, together with high-
resolution spinning disk confocal z-stack mosaics, we characterized the earliest presymptomatic cortical LVPN morphologic and elec-
trophysiological perturbations in hSOD1G93A (SOD1) mice to date. Apical dendritic regression occurred from postnatal day (P) 28,
dendritic spine loss from P21, and increased EPSC frequency from P21 in SOD1 LVPNs. These findings demonstrate extensive early
changes in motor cortex of the SOD1mousemodel, which thus recapitulates clinically relevant cortical pathophysiology more faithfully
than previously thought.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegen-
erative disorder clinically characterized by loss of upper motor
neurons of the motor cortex and corticospinal tract, including
layer V pyramidal neurons (LVPNs) and loss of brainstem and
spinal cord lower motor neurons (MNs), causing muscle weak-
ness and death within 3–4 years from onset (Turner et al., 2013).
Cu/Zn-superoxide dismutase (SOD1) mutations in familial ALS
(Rosen et al., 1993) have provided key pathogenic insights into
ALS, through the use of transgenic mice overexpressing the mu-
tant human hSOD1G93A gene, which exhibit progressive MN de-
generation resembling human ALS (Gurney et al., 1994).
Although ALS is an adult-onset disease, pathogenic lower MN
changes in theSOD1model occur from late embryogenesis onwards
(van Zundert et al., 2008; Vinsant et al., 2013). Studies of SOD1
models have largely focused on understanding lower MN and pe-
ripheral nervous system pathology, overlooking important cortical
and subcortical clinical features of humanALS (Turner et al., 2013).
Clinically, motor cortex LVPNs are reduced in ALS (Mochi-
zuki et al., 2011). Golgi-impregnated human LVPNs show den-
dritic degeneration, “stumped” apical dendrites that do not reach
the pia, dendritic spine loss and somatic swellings (Hammer et
al., 1979). In addition, cortical hyperexcitation, proposed as a key
determinant in clinical progression (Bae et al., 2013), may occur
before clinical symptoms (Vucic et al., 2008) and separates ALS
from other neuromotor disorders (Vucic et al., 2011). Support
for cortical involvement in the etiology of human ALS comes
from clinical observations that brainstem and spinal motor nu-
clei without direct cortical connections (oculomotor, abducens,
and Onuf’s nuclei) are relatively spared during the disease (Eisen
et al., 1992).
In the mutant SOD1 mouse model, corticospinal neurons (a
type of LVPN) display somatic abnormalities at postnatal day (P)
30 (Ozdinler et al., 2011)with cell loss, autophagic apical dendrite
degeneration, and spine loss by P60 (Jara et al., 2012). Addition-
ally, cortical cultures from SOD1mice show intrinsic hyperexcit-
ability (Pieri et al., 2009).
This study aimed to determine the extent and timing of den-
dritic degeneration and nature of LVPN functional synaptic in-
puts at presymptomatic ages P21–P27, beginning after rapid
increases in cortical volume and connectivity have plateaued
(Bahrey and Moody, 2003; Ingalhalikar et al., 2014), and P28–
P40, beginning with the earliest reported motor behavior defects
and muscle denervation at P28 (Vinsant et al., 2013) and ending
when corticospinal neuron loss begins (Ozdinler et al., 2011).
Using dye-filling and whole-cell patch clamping in conjunction
with spinning disk confocal neuronal imaging, we report early
regression of LVPN dendritic arbors and spines, along with si-
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multaneous increases in functional excitatory neurotransmis-
sion. Our findings suggest that excessive spontaneous synaptic
excitatory neurotransmission in the motor cortex is correlated
with dendritic regression of LVPNs before neuronal death and
other ALS-like symptoms.
Materials andMethods
Mice. A total of 16 male and 25 female age-matched and litter-matched
wild-type (WT) and heterozygous transgenic mice overexpressing the
hSOD1G93Amutationwere used. The percentage ofWTand SOD1males
was similar for each age studied (P21–P27, 33%; P28–P40, 42%). All
procedures were approved by The University of Queensland Animal
Ethics Committee and complied with national ethical guidelines.
Slice preparations. Mice were anesthetized with sodium pentobarbi-
tone (60–80 mg/kg, i.p.; Vetcare) and decapitated. During dissection,
the tissuewas bathed in ice-cold high-Mg2Ringer’s solution containing
the following (in mM): 130 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 5
MgCl2, 1 CaCl2, and 10 D-glucose. Ringer’s solutions were continuously
bubbled with 95% O2/5% CO2 to maintain pH at 7.4. Off-coronal slices
(300 m) with a 15° rostral rotation containing motor cortex were cut
using a vibratome (Leica VT 1200S, Leica Biosystems). Slices were incu-
bated for 60 min in high-Mg2 Ringer’s solution warmed to 34°C and
then moved to a normal Ringer’s (1 mM MgCl2, 2 mM CaCl2) solution
maintained at 22°C for 30 min before start of recording and labeling.
Electrophysiology. Patch electrodes were pulled from borosilicate glass
capillaries (EdwardsMedical) giving a tip resistance of 3–4M and filled
with intracellular solution containing the following (in mM): 135
CsMeSO4, 6 KCl, 1 EGTA, 2 MgCl2, 5 Na-HEPES, 3 ATP-Mg
2, 0.3
GTP-Tris, pH 7.25 (osmolarity, 305  5 mOsm; Kanjhan and Belling-
ham, 2013). The pipette was then back-filled with 1–2 l of intracellular
solution containing 2%Neurobiotin (NB; Vector Laboratories). A single
brain slice was stabilized with a metal mesh in a tissue chamber on a
Nikon E600FN microscope fitted with infrared-differential interference
contrast optics, continuously superfused (1–2 ml/min) with normal
Ringer’s solution at 22°C, and viewed on amonitor through a 60water-
immersion objective and an infrared video camera (Hamamatsu). Re-
cordings and voltage pulse protocols were made with an Axopatch 1D
amplifier (Molecular Devices). Data were sampled at 10 kHz and low-
pass filtered at 2 kHz using PClamp 10.2 software and a Digidata 1332A
digitizer (Molecular Devices). A patch electrode was advanced toward
visually identified LVPNs in the motor cortex with a micromanipulator
(Sutter Instrument). Gentle suction was applied until a stable seal of
300–1000 M was obtained. The NB electroporation procedure was
modified from that described for brainstem MNs. Square-wave voltage
steps (0.5 s, 1 Hz) of 5–25 mV that generated current pulses of 300–500
pA were applied for 3–5 min. If the membrane seal was ruptured by
voltage pulses or suction, spontaneous IPSCs and EPSCs were recorded
at holding membrane potentials of 0 mV and 70 mV respectively.
Spontaneous synaptic events were detected over 75 s of continuous record-
ing, chosen randomly from 2 min epochs, using Axograph X (Axograph
Scientific). Peak-to-peak noise ranged from2 to 10 pA, and only eventswith
peak amplitudes of2 half peak-to-peak noise were analyzed.
Immunocytochemistry and imaging. After filling, slices were left in the
bath for5 min to allow NB diffusion, then fixed in 4% paraformalde-
hyde in 0.1 M PBS for 30min, washed in PBS and incubated for 4 h in PBS
containing 4% bovine serum albumin (BSA) and 0.05% Triton X-100 at
4°C. Slices were then incubated for 4 h at 4°C in Cy3-streptavidin (Sigma-
Aldrich; 1:500 in 4% BSA PBS) to visualize NB. Slices were washed in PBS
and mounted on slides. High-resolution 60 water-immersion objective
mosaic z-stacks (0.33 m z-steps) of LVPNs were captured using a W1
Yokogawa spinning disk confocal scanner (Yokogawa Electric) equipped
with a Flash 4.0 scientific complementarymetal-oxide semiconductor cam-
era (Hamamatsu).
Morphologic quantification. Morphological properties of NB-filled
LVPNs were analyzed from confocal images using Neurolucida (MBF
Bioscience). Dendrites were divided into apical or basal; small processes
were classified as spines only if they were 	3 m long and 	0.8 m in
cross-sectional diameter (Harris, 1999). A total LVPN dendrite length of
222,602mwas traced for length and spine density in 44 individual LVPNs.
Statistical analysis. Data were analyzed with Prism 6 (Graphpad) and
expressed as mean  SE. Statistically significant differences were deter-
mined using two-way ANOVAs with Bonferroni’s post-test, where *p	
0.05, **p 	 0.01, ***p 	 0.001, and ****p 	 0.0001 were statistically
significant. A power analysis (GPower3; Faul et al., 2007) showed that
sample size could detect an effect size of 0.25 with p 0.8.
Results
Regression of apical dendritic arbor length in SOD1 LVPNs
The elongated apical and short basal dendritic structure ofmotor
cortex LVPNs facilitate integration of divergent sources of syn-
aptic inputs to produce coordinated motor outputs. Changes in
LVPN dendritic structure are therefore likely to affect synaptic
transmission onto the LVPN and compromise neuromotor func-
tion. To assess dendritic arborization in LVPNs of WT and SOD1
mice, we studied LVPNmorphology at two developmental stages in
presymptomaticSOD1miceand inage-matchedand litter-matched
WT controls: P21–P27, after the end of rapid functional and mor-
phological cortical maturation (Bahrey and Moody, 2003; Ingal-
halikar et al., 2014), and P28–P40 (Fig. 1A,B), after the onset of
hindlimb motor weakness and muscle denervation (Vinsant et al.,
2013).
Total LVPN dendritic length was unchanged at P21–P27
(WT, 4864 450 m, n
 6; SOD1, 3580 623 m, n
 9; p

0.31; Fig. 1G). By lower MN symptom onset at P28–P40, SOD1
LVPN dendritic arbors decreased by 31% compared with WT
(WT, 6622  418 m, n 
 14; SOD1, 4566  479 m, n 
 15;
**p 
 0.0044; Fig. 1G). Mean LVPN apical arbor length was
unchanged at P21–P27 (WT, 3122  521 m, n 
 6; SOD1,
1693  624 m, n 
 9; p 
 0.10; Fig. 1H). By P28–P40, SOD1
LVPN apical arbors were decreased by 49% compared with WT
(WT, 3951  354 m, n 
 14; SOD1, 2028  379 m, n 
 15;
***p 
 0.0009; Fig. 1H). Mean LVPN apical terminal distance
from somawas unchanged at P21–P27 (WT, 724 40m, n
 6;
SOD1, 492 93m, n
 9; p
 0.16). By P28–P40, SOD1 LVPN
apical terminal distances from the soma were decreased by 33%
compared withWT (WT, 762 52m, n
 14; SOD1, 511 77
m, n 
 15; *p 
 0.017). By contrast, LVPN basal arbor length
was unchanged at both P21–P27 (WT, 2290  327 m, n 
 6;
SOD1, 1497  366 m, n 
 9; p 
 0.61) and P28–P40 (WT,
2930  444 m, n 
 14; SOD1, 2691  407 m, n 
 15; p 
0.99). There was no difference in LVPN soma size between SOD1
andWTat P21–P27 (WT, 1570 379m3, n
 6; SOD1, 1588
161 m3, n
 9; p 0.99) and P28–P40 (WT, 2273 255m3,
n 
 14; SOD1, 1979  204 m3, n 
 15; p 
 0.68; but see
Ozdinler et al., 2011; Jara et al., 2012).
These observations suggest that LVPN apical dendritic arbors
in the motor cortex undergo selective recession at presymptom-
atic stages of the SOD1 mouse model. This recession was clearly
evident at P28–P40, when muscle denervation has begun, but
before lowerMN loss at P35–P60 (Ngo et al., 2012; Vinsant et al.,
2013). Apical dendrite “degeneration” of identified corticospinal
neurons has previously been reported in SOD1 mice at P60. Our
data show striking shrinkage in SOD1 LVPN dendritic arbors by
P28 and continuing to P40, due to reduction in apical dendrite
length, both in extent to the pia and in decreased apical collateral
branch length and number.
Decreased apical and basal spine densities in SOD1 LVPNs
A reduction in the apical dendritic arbor of SOD1 LVPNs could
alter the number of presynaptic inputs onto these neurons. Ex-
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citatory presynaptic inputs to LVPNs are usually associated with
dendritic spines (Spruston, 2008; Yu and Zuo, 2011). We there-
fore examined morphological spine density in motor cortex
LVPNs from SOD1 mice and their age-matched littermates by
quantifying the number of spines per 100 m length of dendrite
in both apical and basal dendritic LVPN trees. The mean apical
dendritic spine density decreased by 56% at P21–P27 (WT,
81.8 6.6, n
 6; SOD1, 36.2 7.3, n
 9; ****p	 0.0001; Fig.
1C,D, I) and by 59% at P28–P40 (WT, 53.3 4.1, n
 14; SOD1,
21.6 2.5, n
 15; ****p	 0.0001; Fig. 1E,F,I). The mean basal
dendritic spine density also decreased by 45% at P21–P27 (WT,
74.6 6.1, n
 6; SOD1, 41.3 8.2, n
 9; ***p
 0.009; Fig. 1J)
Figure 1. Apical dendritic regression, spine loss, and increased EPSC frequency occurs inmotor cortex LVPNs of presymptomatic SOD1mice.A,B, Dendritic arbors of NB-filled LVPNswithin primarymotor
cortexfromWT(A)andSOD1(B)mice.C–F,LVPNsshowdecreasedapicaldendriticspinesinP23andP31SOD1micecomparedwithage-matchedandlitter-matchedWTmice.G–J,Scatterplotsofmorphological
measurements inP21–P27andP28–P40SOD1andWTLVPNs,showingdecreasedtotaldendriticarbor lengthinP28–P40SOD1LVPNs(G),decreasedapicaldendriticarbor lengthinP28–P40SOD1LVPNs(H ),








 6 (P21–P27) andn
 13 (P28–P40); SOD1,n
 5 (P21–P27) andn
 19 (P28–P40). Scale bars:A,B, 250m; C–F, 5m.
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and by 52% at P28–P40 (WT, 52.2 3.7, n
 14; SOD1, 25.3
2.3, n
 15; ****p	 0.0001; Fig. 1J).
These data suggest that postsynaptic alterations occur in mo-
tor cortex LVPNs as early as P21 and that loss of spines occurs
across the entire dendritic arbor. Spine reductions in apical, but
not basal, dendrites of corticospinal neurons have been previ-
ously reported in P60 SOD1 mice (Jara et al., 2012).
Increased frequency of spontaneous excitatory
neurotransmission in SOD1 LVPNs
Spine density reductions associated with glutamate-induced ex-
citotoxicity have been described for decades (Olney, 1971) and
spine and/or synaptic dysfunction may precede neuronal cell
death in many neurodegenerative diseases (Luebke et al., 2010),
including the SOD1 model of ALS (van Zundert et al., 2008). As
glutamate is the most abundant excitatory neurotransmitter and
excitatory synaptic activity is apotent regulatorofdendrite andspine
dynamics (Yu and Zuo, 2011), we quantified excitatory and inhibi-
tory synaptic activity in motor cortex LVPNs, using whole-cell
patch-clamp recordings from presymptomatic SOD1 and age-
matched littermate controls, for P21–P27 and P28–P40 age groups.
At70 mV, all spontaneous inward currents were excitatory.
The mean frequency of spontaneous EPSCs in SOD1 LVPNs in-
creased by 141% at P21–27 (WT, 0.76 0.12 Hz, n
 6; SOD1,
1.82  0.31 Hz, n 
 5; *p 
 0.013; Fig. 1K,L, top row) and by
85%at P28–P40 (WT, 0.83 0.12Hz,n
 13; SOD1, 1.54 0.17
Hz, n 
 19; **p 
 0.005; Fig. 1K,L, bottom row). By contrast,
EPSC shape parameters (10–90% rise time, amplitude, and half-
width) and LVPN electrophysiological parameters remained un-
changed across the two genotypes over the two age groups. The
mean EPSC shape and electrophysiological parameters were as
follows: (1) 10–90% rise time (P21–P27: WT, 3.0 0.7 ms, n

6; SOD1, 3.8 1.2 ms, n
 5; p 0.99; P28–P40: WT, 2.9 0.4
ms, n
 13; SOD1, 3.1 0.5ms, n
 19; p 0.99), (2) amplitude
(P21–P27: WT, 30.6 9.2 pA, n
 6; SOD1,26.1 7.2 pA,
n
 5; p 0.99; P28–P40: WT,16.6 3.0 pA, n
 13; SOD1,
18.9 2.4 pA, n
 19; p 0.99), and (3) half-width (P21–P27:
WT, 4.2 0.9 ms, n
 6; SOD1, 6.1 1.0 ms, n
 5; p
 0.58;
P28–P40:WT, 4.9 0.9ms, n
 13; SOD1, 4.0 0.7ms, n
 19;
p
 0.35); (4) membrane capacitance (P21–P27: WT, 22 3 pS,
n
 6; SOD1, 28 4 pS, n
 5; p
 0.55; P28–P40: WT, 32 2
ms, n
 13; SOD1, 26 2ms, n
 19; p
 0.06); and (5) holding
current at 70 mV (P21–P27: WT, 208  129 pA, n 
 6;
SOD1,21 10 pA, n
 5; p
 0.09; P28–P40:WT,174 38
pA, n
 13; SOD1,70 22 pA, n
 19; p
 0.12).
At 0 mV, all spontaneous outward currents were inhibitory.
There were no differences between SOD1 andWT LVPN IPSC pa-
rameters at all ages studied, including IPSC frequency, 10–90% rise
time, amplitude, andhalf-width.Themean IPSCparameterswere as
follows: (1) frequency (P21–P27:WT, 2.45 0.49Hz,n
 6; SOD1,
2.47 0.40Hz,n
 7; p 0.99; P28–P40:WT, 2.37 0.25Hz,n

14; SOD1, 1.52 0.22 Hz, n
 20; p
 0.21); (2) 10–90% rise time
(P21–P27:WT, 3.5 0.7ms,n
 6; SOD1, 5.6 1.7ms,n
 7; p

0.26; P28–P40:WT, 3.5 0.6ms, n
 14; SOD1, 4.3 0.4ms, n

20; p
 0.68); (3) amplitude (P21–P27: WT, 13.4 2.9 pA, n
 6;
SOD1, 12.33.8 pA,n
7;p0.99; P28–P40:WT, 14.32.0 pA,
n
 14; SOD1, 11.8 1.8 pA, n
 20; p
 0.74), and (3) half-width
(P21–P27:WT, 9.2 3.1ms,n
 6; SOD1, 6.3 1.2ms,n
 7; p

0.36; P28–P40:WT, 7.6 0.8ms, n
 14; SOD1, 7.7 0.8ms, n

20; p 0.99).
Together, our patch-clamp data suggest motor cortex LVPNs
of SOD1 mice receive increased excitatory neurotransmission as
early as P21, without compensatory increases in inhibitory neu-
rotransmission. Thismay lead to glutamate-induced excitotoxic-
ity, recognized as one of the main pathogenic triggers of ALS and
other neurodegenerative disorders (Bogaert et al., 2010).
Discussion
Selective degeneration of both upper and lower MNs is patho-
gnomonic for ALS. While lower MN loss and dysfunction have
been increasingly well characterized in animal models of ALS
(Gurney et al., 1994; van Zundert et al., 2008; Ngo et al., 2012;
Vinsant et al., 2013; Delestre´e et al., 2014), there have been few
investigations of cortical changes in these models (Pieri et al.,
2009; Ozdinler et al., 2011; Jara et al., 2012). The morphological
and electrophysiological changes reported here strongly support the
early onset ofmotor cortical dysfunction in the SOD1mousemodel
of ALS. Changes are evident from P21, persist up to the onset of
LVPN loss fromP35 (Ozdinler et al., 2011), andprecede the onset of
lower MN symptoms from P28 onwards (Vinsant et al., 2013) and,
according toprevious reports, theonset of apical dendrite regression
and spine loss in corticospinal neurons at P60 (Jara et al., 2012).
While we have not identified the projection target of the
LVPNs recorded here, our sample is highly likely to contain cor-
ticospinal neurons, as 45% of motor cortex LVPNs are retro-
gradely labeled by spinal tracer injection (Brecht et al., 2013).We
found a significant decline in both apical and basal dendritic
spine density of SOD1 LVPNs from P21, 3–5 weeks earlier than
previously reported in apical (but not basal) dendrites of SOD1
corticospinal neurons (Jara et al., 2012). Dendritic loss in SOD1
LVPNs was confined to apical dendrites, both in reduced exten-
sion of the apical dendrite toward the pia and reduction in the
oblique apical branches within layer II/III. Both spine loss and
dendrite regression occurred before symptom onset and cortico-
spinal neuron loss. These observations in hSOD1G93A mice are
consistent with the selective vulnerability of cortical neurons in
ALS seen in human pathology (Hammer et al., 1979).
Pyramidal neurons, such as LVPNs, are typically covered with
thousands of dendritic spines, predominantly constituting the
postsynaptic domains of glutamatergic synapses (Spruston,
2008). Apical dendritic spines of motor cortex LVPNs receive
excitatory inputs from thalamocortical neurons and from local
and contralateral layer II/III neurons (Jara et al., 2012; Brecht et
al., 2013; Hooks et al., 2013). Basal dendritic spines preferentially
receive excitatory inputs from thalamic sensory andmotor nuclei
and from secondary motor cortex (Hooks et al., 2013). We saw in-
creased functional excitatory synaptic activity onto SOD11 LVPNs,
compared with controls, at all ages studied. By contrast, inhibitory
synaptic activity in LVPNs was unchanged. Increased EPSC activity
and excessive glutamate release is consistent with decreased spine
density (Hasbani et al., 2001) and with excitotoxicity as a key etio-
logical driver in ALS (Bogaert et al., 2010; Turner et al., 2013).
It is intriguing that increased EPSC activity has previously been
shown in developing lower MNs from SOD1mice (van Zundert et
al., 2008). Our results support the possibility that one factor under-
lying increased synaptic activity in lower MNs may be increased
activity in LVPNs, which regulate lowerMN activity via projections
to the brainstem and spinal cord. Alternatively, increased glutamate
release at synapsesmade onto LVPNs andonto lowerMNsmaybe a
common pathological process leading to their demise in ALS.
Our observation that dendritic spine loss correlated with in-
creased EPSC frequency in SOD1 LVPNs was surprising, as den-
dritic spines are considered a canonical part of excitatory
synapses (Spruston, 2008). However, cultured cortical neurons
remain in synaptic contact with one another even after glutamate
receptor-induced spine loss (Hasbani et al., 2001). Alternatively,
646 • J. Neurosci., January 14, 2015 • 35(2):643–647 Fogarty et al. •Motor Cortex Changes in Presymptomatic ALS Mice
spine loss may trigger functional compensation by LVPNs, such
as increased persistent inward currents, a feature of presymptom-
atic in vitro SOD1 cortical neurons (Pieri et al., 2009), to amplify
remaining synaptic inputs (Heckman et al., 2008).
Taken in total, our results demonstrate presymptomatic alter-
ations in SOD1 LVPN dendritic arbors, spine density, and spon-
taneous synaptic inputs that are evident at P21 and are
maintained until P40, when corticospinal neuron loss has begun
(Ozdinler et al., 2011). These findings suggest that corticospinal
neuron death in the hSOD1G93A model of ALS is preceded by
presymptomatic cellular alterations that are likely to cause exten-
sive perturbations of the motor cortex neural network. We note
that the presence of direct corticospinal inputs to MNs clearly
differs between species. Primates (including humans) have vary-
ing levels of direct inputs, ranging from strong for distal hand
muscles to weak for proximal limb muscles (for review, see
Lemon, 2008). By contrast, functional direct corticospinal inputs
to forelimb MNs are lacking in mouse (Alstermark and Ogawa,
2004), although some morphological evidence exists for direct
corticospinal contacts on mouse lumbar MNs (Bareyre et al.,
2005). Despite these species differences, our demonstration that
morphological and functional changes in mouse LVPNs occur
before, or are synchronous with, lower MN loss, suggests that
direct corticospinal connections may be less important in ALS
pathogenesis than previously thought. These changes in the mo-
tor cortex of hSOD1G93A mice increase the parallels between this
model and well established upper and lower MN symptoms evi-
dent in clinical ALS (Vucic et al., 2011), suggesting that the
hSOD1G93A mouse will be useful for investigation of the mecha-
nisms and exact chronology of cortical degeneration in ALS.
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